Einträge von Fante, Matthias auf dem Publikationsserver

Denk, Alexander , Mittermaier, Cornelia, Weber, Daniela, Fante, Matthias, Güneş, Sibel, Edinger, Matthias, Herr, Wolfgang und Wolff, Daniel (2024) Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis. Annals of Hematology 103, S. 3755-3764.

Denk, Alexander , Edinger, Matthias, Weber, Daniela, Holler, Ernst, Fante, Matthias, Meedt, Elisabeth, Güneş, Sibel, Poeck, Hendrik, Mittermaier, Cornelia, Herr, Wolfgang und Wolff, Daniel (2024) Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis. Annals of Hematology 103, S. 3071-3081.

Derigs, Patrick, Bethge, Wolfgang A., Krämer, Isabelle, Holtick, Udo, von Tresckow, Bastian, Ayuk, Francis, Penack, Olaf, Vucinic, Vladan, von Bonin, Malte, Baldus, Claudia, Mougiakakos, Dimitrios, Wulf, Gerald, Schnetzke, Ulf, Stelljes, Matthias, Fante, Matthias, Schroers, Roland, Kroeger, Nicolaus und Dreger, Peter (2023) Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation Analysis. Transplantation and Cellular Therapy 29 (12), S. 750-756. Volltext nicht vorhanden.

Kayser, Sabine, Sartor, Chiara, Luskin, Marlise R. , Webster, Jonathan, Giglio, Fabio, Panitz, Nydia, Brunner, Andrew M., Fante, Matthias, Lutz, Christoph, Wolff, Daniel, Ho, Anthony D., Levis, Mark J., Schlenk, Richard F. und Papayannidis, Cristina (2022) Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and <i>BCR-ABL</i>-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin. Haematologica 107 (9), S. 2064-2071. Volltext nicht vorhanden.

Wertheimer, Tobias , Dohse, Marius, Afram, Gabriel, Weber, Daniela, Heidenreich, Martin, Holler, Barbara, Kattner, Anna-Sophia, Neubauer, Andreas, Mielke, Stephan, Ljungman, Per, Holler, Ernst, Herr, Wolfgang, Edinger, Matthias, Martínez, Antonio Pérez, Fante, Matthias und Wolff, Daniel (2021) Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis. Annals of Hematology 100, S. 779-787.

Renner, Kathrin , Bruss, Christina, Schnell, Annette, Koehl, Gudrun, Becker, Holger M., Fante, Matthias, Menevse, Ayse-Nur, Kauer, Nathalie, Blazquez, Raquel, Hacker, Lisa, Decking, Sonja-Maria, Bohn, Toszka, Faerber, Stephanie, Evert, Katja, Aigle, Lisa, Amslinger, Sabine, Landa, Maria, Krijgsman, Oscar, Rozeman, Elisa A., Brummer, Christina, Siska, Peter J., Singer, Katrin, Pektor, Stefanie, Miederer, Matthias, Peter, Katrin, Gottfried, Eva, Herr, Wolfgang, Marchiq, Ibtisam, Pouyssegur, Jacques, Roush, William R., Ong, SuFey, Warren, Sarah, Pukrop, Tobias , Beckhove, Philipp , Lang, Sven A., Bopp, Tobias, Blank, Christian U., Cleveland, John L., Oefner, Peter J., Dettmer, Katja , Selby, Mark und Kreutz, Marina (2019) Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy. Cell Reports 29 (1), 135-150.e9.

Renner, Kathrin, Seilbeck, Anton, Kauer, Nathalie, Ugele, Ines, Siska, Peter J., Brummer, Christina, Bruss, Christina, Decking, Sonja-Maria, Fante, Matthias, Schmidt, Astrid, Hammon, Kathrin, Singer, Katrin, Klobuch, Sebastian, Thomas, Simone , Gottfried, Eva, Peter, Katrin und Kreutz, Marina (2018) Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells. Frontiers in Pharmacology 9 (1258), S. 1-13.

Fante, Matthias (2018) Impact of an anti-metabolic therapy on leukemic and non-malignant T cells. Dissertation, Universität Regensburg.

Renner, Kathrin, Geiselhöringer, Anna-Lena, Fante, Matthias, Bruss, Christina, Färber, Stephanie, Schönhammer, Gabriele, Peter, Katrin, Singer, Katrin, Andreesen, Reinhard, Hoffmann, Petra, Oefner, Peter J. , Herr, Wolfgang und Kreutz, Marina (2015) Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2-deoxy-glucose affects effector functions. Eur J Immunol 45 (9), S. 2504-2516. Volltext nicht vorhanden.